Company Directory > MedTech > JASCO Corporation
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of JASCO Corporation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
JASCO Corporation is a global leader in the design and manufacture of high-precision analytical instrumentation, primarily focusing on optical spectroscopy and chromatography. Founded in 1958, the company provides advanced solutions for academic, pharmaceutical, biotechnology, forensics, and industrial research laboratories worldwide. Their product portfolio includes Fourier Transform Infrared (FTIR) spectrometers, Raman spectrometers, UV-Visible/NIR spectrophotometers, circular dichroism (CD) spectrometers, and comprehensive HPLC/UHPLC and Supercritical Fluid Chromatography (SFC) systems. JASCO is recognized for its expertise in optical design and its commitment to supporting method development and applications research for its global customer base.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Analytical Instrumentation
SIZE & FINANCIALS
Employees:501-1000
Founded:1958
Ownership:private
Status:operating
0
CORPORATE STRUCTURE
Subsidiaries:JASCO International Co., Ltd., JASCO Inc. (USA), JASCO Europe s.r.l.
Key Partnerships:Evident Scientific (formerly Olympus) - Collaboration on microscopy optics for Raman systems
COMPETITION
Position:Leader
Competitors:Sartorius, Cepheid, Unchained Labs, Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific
LINKS
Website:jasco.co.jp
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with JASCO Corporation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.